In Brief: Flu vaccine '95-'96
Flu vaccine '95-'96: Should incorporate an A(H3N2) component of a Johannesberg/33/94-like strain and a B component of a Beijing/184/93-like strain, FDA's Vaccines & Related Biologics Advisory Committee recommends March 17. The committee already had recommended an A(H1N1) Texas/36/91-like strain as the third component at its January meeting ("The Pink Sheet" Jan. 30, T&G-2). The strains selected are consistent with those chosen by the World Health Organization Feb. 17, the committee says..
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth